| Read Time: 4 minutes | Class Actions

New York Times: It’s Time for a Reckoning on Medical Devices

The New York Times recently published a comprehensive look at how patients suffer when companies and regulators fail to effectively screen or monitor defective medical devices on the market. In the past decade, nearly two million injuries and more than 80,000 deaths have been linked to faulty medical devices, many approved with little to no clinical testing, according to a global...

Continue Reading

| Read Time: 2 minutes | Defective Products

Bayer Reeling After Spending Summer in Spotlight for Dangerous Products

Bayer AG faces more than 8,700 plaintiffs across the U.S. alleging that recently-acquired Monsanto’s glyphosate-based weed killers such as Roundup® and Ranger Pro® cause cancer. The international pharmaceutical and agricultural giant recently acquired Monsanto in a $63 billion deal completed in June 2018, taking on a daunting set of lawsuits. The number of lawsuits against Monsanto has risen from...

Continue Reading

| Read Time: 2 minutes | Defective Products

Netflix Documentary ‘The Bleeding Edge’ Exposes Dangerous Medical Devices

From birth-control devices to hip implants, the majority of medical devices hit the market without proper testing. Sometimes these untested devices, meant to improve lives, ruin them instead. Pharmaceutical and medical device companies make billions. Patients often pay with their health. These are the horrors exposed in the terrifying new documentary “The Bleeding Edge.” The film, which releases July 27 on...

Continue Reading

| Read Time: < 1 minute | Defective Products

Essure Permanent Birth Control Dangers Featured on Good Morning America

As featured today on “Good Morning America,” Bayer Pharmaceuticals announced that it will no longer sell the controversial permanent birth control implant Essure starting at the end of this year. The move follows thousands of lawsuits, as women stand up to “Big Pharma” and hold corporations responsible for serious injuries such as device migration, organ perforation, internal bleeding, hysterectomies, and...

Continue Reading

| Read Time: 3 minutes | Essure Birth Control

Bayer Discontinues Controversial Essure® Permanent Birth Control

Today, pharmaceutical giant Bayer announced it was discontinuing sales of its Essure® birth control device, no longer selling or distributing the product after December 31, 2018. This announcement comes after the U.S. Food & Drug Administration (FDA) took an extraordinary step in April by limiting sales to doctors who ensured that they were actively informing women of the risks associated...

Continue Reading